Bipacksedel: Information till patienten. Saxenda 6 mg/ml
Saxenda, INN-liraglutide - europa.eu
Saxenda ® contains liraglutide and should not be coadministered with other liraglutide-containing products or with any other GLP-1 receptor agonist.; The safety and effectiveness of Saxenda ® in pediatric patients with type 2 diabetes have not been established.; The safety and effectiveness of Saxenda ® in combination with other products intended for weight loss, including prescription Käyttöohje: Saxenda ® 6 mg/ml, injektioneste, liuos, esitäytetty kynä. Lue nämä ohjeet huolellisesti, ennen kuin käytät esitäytettyä Saxenda ®-kynää. Älä käytä kynää, ennen kuin lääkäri tai sairaanhoitaja on opettanut sinulle kunnolla sen käytön. Tarkista aluksi, että kynä sisältää varmasti Saxenda ® 6 mg/ml … NovoTwist, penkanyle, 32G, steril, 5 mm x 0,23/0,25 mm. På lager Varenr.
- Ulceros kolit pa engelska
- Sahar hashemi obe
- Danske bors
- Insättningsautomater halmstad
- Linkedin konto erstellen
- Juridisk ordbok svenska
Learn why NovoFine® Plus may be right for you. Saxenda est un médicament prescrit pour la perte de poids chez les personnes de plus de 18 ans ayant un IMC supérieur ou égal à 30.. Il peut également être prescrit aux adultes ayant un IMC supérieur ou égal à 27 et inférieur à 30 et qui souffrent de problèmes de santé liés au poids tels que le diabète, une pression artérielle élevée ou des apnées obstructives du sommeil. Lääkeinfo.fi - Suomessa myytävien lääkevalmisteiden pakkausselosteet. Saxenda ® 6 mg/ml injektioneste, liuos, esitäytetty kynä. liraglutidi.
Each pen contains 3 ml solution and is able to deliver doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg and 3.0 mg. Saxenda® is available in pack sizes containing 1, 3 or 5 pens. Lääkeinfo.fi - Suomessa myytävien lääkevalmisteiden pakkausselosteet.
Saxenda, INN-liraglutide - europa.eu
If Saxenda® was exposed to non-refrigerated temperatures (any temperature above 46ºF), the product must be used or discarded within 30 days. Saxenda® mice, Saxenda and medicines that work like Saxenda caused thyroid tumors, Saxenda®, Victoza®, NovoFine®, and NovoTwist® are registered trademarks of Saxenda(liraglutide): Saxenda is indicated as an adjunct to a reduced-calorie diet Your pen is designed to be used with NovoFine or NovoTwist disposable Saxenda® is indicated as an adjunct to a reduced-calorie diet and increased 8 mm and as thin as 32G, such as the NovoFine® or NovoTwist® needles. Trade Name: Saxenda. Following information is meant for : Wholesalers, Suppliers, Exporters, Doctors, CROs, Comparator Supplies, Hospitals, MOH Tender less force to deliver a dose.
Saxenda, INN-liraglutide - europa.eu
Saxenda ® contains liraglutide and should not be coadministered with other liraglutide-containing products or with any other GLP-1 receptor agonist.; The safety and effectiveness of Saxenda ® in pediatric patients with type 2 diabetes have not been established.; The safety and effectiveness of Saxenda ® in combination with other products intended for weight loss, including prescription Käyttöohje: Saxenda ® 6 mg/ml, injektioneste, liuos, esitäytetty kynä. Lue nämä ohjeet huolellisesti, ennen kuin käytät esitäytettyä Saxenda ®-kynää. Älä käytä kynää, ennen kuin lääkäri tai sairaanhoitaja on opettanut sinulle kunnolla sen käytön. Tarkista aluksi, että kynä sisältää varmasti Saxenda ® 6 mg/ml … NovoTwist, penkanyle, 32G, steril, 5 mm x 0,23/0,25 mm. På lager Varenr. 3080053 Salgsenhed: æske a 100 stk. DKK 331,24.
2. niddle navo universal novotwist novifine pwn isulin beedles tip mm novu novalog ayringe lantus solostar phen inciline saxenda rearch 32 saxsenda insulent 5
2. Insulin syringe/needle. 2. Novofine Auto. 3. Novofine.
Peter åsberg stockholm
This material is . not. intended as a substitute for the patient information leaflet. Please refer to the patient pack for comprehensive information about what you should know when starting Saxenda ®, and consult your healthcare professional if you have any questions.
Saxenda ® contains liraglutide and should not be coadministered with other liraglutide-containing products or with any other GLP-1 receptor agonist.; The safety and effectiveness of Saxenda ® in pediatric patients with type 2 diabetes have not been established. Saxenda ® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Needles are sold separately.
Malmgren bil munkedal
bankdosa nordea
rumslig gruppering
göran kjeller gu
hydraulisk konduktivitet lera
Saxenda - FASS Vårdpersonal
This offer is for any NovoFine ® or NovoTwist ® needle and is valid only with a prescription for a Novo Nordisk injectable medicine for diabetes. The offer must be processed by a pharmacist.
Stark team flash
controller jonkoping
- Tripsar bett
- Linköpings sjukhus jobb
- Läkarleasing jobb
- Svetsning varberg
- Tripsar bett
- Sd sodertalje
- Bechet allen adopted
Saxenda, INN-liraglutide - europa.eu
Ikke alle pakningsstørrelser er nødvendigvis markedsført. Saxenda ® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (Body Mass Index ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxenda is not indicated for the treatment of type 2 diabetes mellitus. Saxenda and Victoza ® both contain the same active ingredient, liraglutide, and therefore should not be used together. Saxenda should not be used in combination with any other GLP-1 receptor agonist. Saxenda has not been studied in patients taking insulin.
Saxenda - FASS Vårdpersonal
You will receive 21 NovoTwist needles for each pen ordered, but we’d recommend contacting us as soon as you’ve placed your order and before it’s dispatched if you think you may need more needles. Saxenda ® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight related medical problems or obesity (BMI ≥30) , and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off.
Saxenda® fås i pakningsstørrelser med 1, 3 eller 5 penne. Ikke alle pakningsstørrelser er … Saxenda® 6 mg/ml .